Coronavirus SARS-CoV-2 NSP14 (exonuclease) protein (Recombinant 6His, N-terminus) (Ala1-Gln527)
Produktgrößen
10 ug
£ POA
LS-G145885-10UG
Über dieses Produkt
- SKU:
- LS-G145885
- Buffer:
- Sterile solution in PBS, pH 7.4, 10% Glycerol.
- Konzentration:
- 0.48 mg/ml
- Weitere Details:
- The nonstructural protein (nsp) 14 of SARS-CoV 2 was identified as a cap (guanine-N7)-methyltransferase (N7-MTase). Nsp14 of coronaviruses two different activities: an exoribonuclease activity acting on both ssRNA and dsRNA in a 3' to 5' direction and a N7-guanine methyltransferase activity. It may be involved in the proof-reading ability during the viral RNA replication and transcription. GTP, dGTP as well as cap analogs GpppG, GpppA and m7GpppG could be methylated by nsp14.positive-stranded RNA genome of the coronaviruses is translated from ORF1 to yield polyproteins that are proteolytically processed into intermediate and mature nonstructural proteins (nsps). SARS-CoV 2 polyproteins incorporate 16 protein domains (nsps). The putative non-structural protein 2 (nsp2) of SARS-CoV plays an important role in viral transcription and replication, and is an attractive target for anti-SARS drug development.
- Molekulargewicht:
- 62.9 kDa
- Reinheit:
- >85%
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -20[o]C Avoid freeze/thaw cycles.
- Hersteller:
- LifeSpan Biosciences
- Typ:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins
- Datenblatt des Herstellers:145885